<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JBA</journal-id>
<journal-id journal-id-type="hwp">spjba</journal-id>
<journal-id journal-id-type="nlm-ta">J Biomater Appl</journal-id>
<journal-title>Journal of Biomaterials Applications</journal-title>
<issn pub-type="ppub">0885-3282</issn>
<issn pub-type="epub">1530-8022</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0885328211427473</article-id>
<article-id pub-id-type="publisher-id">10.1177_0885328211427473</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>In vitro cytotoxicity and cellular uptake of curcumin-loaded Pluronic/Polycaprolactone micelles in colorectal adenocarcinoma cells</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Raveendran</surname><given-names>Radhika</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Bhuvaneshwar</surname><given-names>GS</given-names></name>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Sharma</surname><given-names>Chandra P</given-names></name>
<xref ref-type="corresp" rid="corresp1-0885328211427473"/>
</contrib>
</contrib-group>
<aff id="aff1-0885328211427473">Facility for nano/microparticles based biomaterials for advanced drug delivery systems (FADDS), Division of Biosurface Technology, Biomedical Technology Wing, Sree Chitra Tirunal Institute for Medical Sciences &amp; Technology, Poojappura, Thiruvananthapuram, Kerala 695012, India</aff>
<author-notes>
<corresp id="corresp1-0885328211427473">Chandra P Sharma, FADDS, Division of Biosurface Technology, Biomedical Technology Wing, Sree Chitra Tirunal Institute for Medical Science and Technology, Poojappura, Thiruvananthapuram 695012, Kerala, India. Email: <email>sharmacp@sctimst.ac.in</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>3</month>
<year>2013</year>
</pub-date>
<volume>27</volume>
<issue>7</issue>
<fpage>811</fpage>
<lpage>827</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Clinical application of curcumin has been limited due to poor aqueous solubility and consequently minimal systemic bioavailability. We investigated the preparation of curcumin-loaded micelles based on amphiphilic Pluronic/Polycaprolactone (Pluronic/PCL) block copolymer, which proved to be efficient in enhancing curcumin’s aqueous solubility. Curcumin-loaded micelles of size below 200 nm was characterized by dynamic light scattering and transmission electron microscopy. The critical micelle concentration (CMC) of the amphiphilic polymer was determined using pyrene as a fluorescent probe. Hemolysis and aggregation studies were investigated to evaluate the blood compatibility of the micelles. Sodium dodecyl sulphate polyacrylamide gel electrophoresis was performed to study the stability of the micelles toward plasma proteins. In vitro cytotoxicity and cellular uptake of the curcumin-loaded micelles were demonstrated in colorectal adenocarcinoma (Caco2) cells. The results indicated that Pluronic/PCL micelles could be a promising candidate for curcumin delivery to cancer cells.</p>
</abstract>
<kwd-group>
<kwd>Micelles</kwd>
<kwd>curcumin</kwd>
<kwd>Pluronic</kwd>
<kwd>cytotoxicity</kwd>
<kwd>cellular uptake</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-0885328211427473" sec-type="intro"><title>Introduction</title>
<p>Bioavailability and efficacy of most of the drugs are affected by their hydrophobic nature. Nanoparticle-mediated drug delivery has reformed the administration of hydrophobic drugs, which have been facing a major setback due to their aqueous insolubility.<sup><xref ref-type="bibr" rid="bibr1-0885328211427473">1</xref>,<xref ref-type="bibr" rid="bibr2-0885328211427473">2</xref></sup> In addition to sequestration and solubilization of hydrophobic drugs, the ability to ultimately release the drugs is also included in the profile of efficient drug delivery systems. During the last 20 years, polymeric drug carriers have immensely gained attention and have emerged as prospective drug delivery systems.<sup><xref ref-type="bibr" rid="bibr3-0885328211427473">3</xref>,<xref ref-type="bibr" rid="bibr4-0885328211427473">4</xref></sup> Studies have been focused on polymeric micelles with self-assembly properties for drug delivery applications.<sup><xref ref-type="bibr" rid="bibr5-0885328211427473">5</xref></sup> Development of polymeric micelles as carriers for hydrophobic drugs provides a set of evident advantages which include efficient solubilization, increased bioavailability, and protection of the incorporated drug from inactivation in biological surroundings. Polymeric micelles have been considered as a versatile nanomedicinal platform due to their greatly improved drug pharmacokinetics and efficacious response in cancer treatment.<sup><xref ref-type="bibr" rid="bibr6-0885328211427473">6</xref></sup> Low water solubility, short blood half-lives, narrow therapeutic indices, and high systemic toxicity are the undesirable factors which have been associated with typical chemotherapeutic agents leading to patient morbidity and mortality. Polymeric micelles have been demonstrated as potent drug carriers by increasing the aqueous solubility of chemotherapeutic agents and prolonging their in vivo half-lives with lessened systemic toxicity.<sup><xref ref-type="bibr" rid="bibr7-0885328211427473">7</xref>–<xref ref-type="bibr" rid="bibr9-0885328211427473">9</xref></sup> Micelles have also been reported to be suitable for enhanced tumor deposition due to the enhanced permeability and retention (EPR) effect stemming from the leakiness of tumor vasculature.<sup><xref ref-type="bibr" rid="bibr10-0885328211427473">10</xref></sup></p>
<p>Curcumin (1,7-bis (4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5 dione), a polyphenol, is a major constituent of turmeric, which is derived from the rhizomes of <italic>Curcuma longa</italic>. Traditional Indian medicine has unlocked various medicinal properties of turmeric. Later, through extensive research, it has been established that curcumin is the key compound in turmeric that imparts the therapeutic properties. Curcumin has been in the limelight ever since its potency for anticancer activity has been proved in various cancer cell lines.<sup><xref ref-type="bibr" rid="bibr11-0885328211427473">11</xref>,<xref ref-type="bibr" rid="bibr12-0885328211427473">12</xref></sup> It has been shown to interact with many cellular targets such as nuclear factor-kappa B (NF-kB), transcription factor activator protein-1 (AP-1), and many other proteins,<sup><xref ref-type="bibr" rid="bibr13-0885328211427473">13</xref>,<xref ref-type="bibr" rid="bibr14-0885328211427473">14</xref></sup> which explains curcumin’s potency for anticancer activity. Curcumin has also been reported to inhibit various interleukins, multiple protein kinases, and suppress the expression of human epidermal growth factor receptor (HER-2), epidermal growth factor receptor (EGFR), and estrogen receptor (ER).<sup><xref ref-type="bibr" rid="bibr15-0885328211427473">15</xref>,<xref ref-type="bibr" rid="bibr16-0885328211427473">16</xref></sup> However, the clinical administration of this active molecule is hampered due to its low aqueous solubility, which further limits its bioavailability. One of the best methods to increase bioavailability is to encapsulate curcumin within the hydrophobic core of a micellar nanocarrier.<sup><xref ref-type="bibr" rid="bibr17-0885328211427473">17</xref>,<xref ref-type="bibr" rid="bibr18-0885328211427473">18</xref></sup> However, despite successful encapsulation, the loading efficiency of curcumin is a factor which gets compromised.</p>
<p>In this study, we report the synthesis of Pluronic/Polycaprolactone (Pluronic/PCL) micelles and encapsulation of curcumin as a model drug into the amphiphilic core to improve its loading efficiency. Pluronic/PCL block copolymers have been previously reported to efficiently encapsulate hydrophobic indomethacin and paclitaxel.<sup><xref ref-type="bibr" rid="bibr19-0885328211427473">19</xref>,<xref ref-type="bibr" rid="bibr20-0885328211427473">20</xref></sup> Curcumin encapsulation in this matrix has not yet been reported, which prompted us to incorporate the amphiphilic copolymer for our study. The PCL was selected as the core to load the hydrophobic curcumin based on its biocompatibility and biodegradability. Pluronic block copolymers are polyethylene oxide-polypropylene oxide-polyethylene oxide triblock (PEO-PPO-PEO) copolymers, which are approved by FDA for pharmaceutical and medical applications. The key attributes of Pluronic block copolymers apart from providing stability to nanoparticles are their ability to enhance drug transport by effective passive targeting toward cancerous tissues and sensitizing the multidrug resistance tumors to various anticancer agents. Due to their amphiphilic character, these copolymers display surfactant properties and further offers stability and biocompatibility to nanoparticles by minimizing the opsonization and prolonging the in vivo circulation of nanoparticles.<sup><xref ref-type="bibr" rid="bibr21-0885328211427473">21</xref></sup> Curcumin loading in Pluronic copolymers has been previously investigated and the matrix afforded a drug loading 5.7% weight by weight (w/w) with an encapsulation efficiency of 34%.<sup><xref ref-type="bibr" rid="bibr22-0885328211427473">22</xref></sup> In this work, we aimed at incorporating hydrophobic PCL with Pluronic as this was considered to increase the loading efficiency of curcumin. Release, cytotoxicity, and cellular uptake profile of the curcumin-loaded Pluronic/PCL matrix were also assessed.</p>
</sec>
<sec id="sec2-0885328211427473" sec-type="materials|methods"><title>Materials and methods</title>
<p>The ε-caprolactone, Pluronic F-127 (molecular weight 12,600 g/mol), stannous octoate, curcumin from <italic>Curcuma longa</italic> (Turmeric; Product no: C1386), pyrene, 3-(4,5-dimethylthiazol-2-yl)−2,5-diphenyl tetrazolium bromide (MTT), and Dulbecco’s modified eagles medium (DMEM) were purchased from Sigma (Bangalore, India). Fetal bovine serum (FBS) was from GIBCO (United States). Colorectal adenocarcinoma (Caco2) cells were obtained from National Centre for Cell Science (Pune, India). All the solvents used in the study were of analytical grade and obtained from Merck (India). The blood experiment which involved collection of blood from healthy volunteers was approved by the Institute Ethics Committee.</p>
</sec>
<sec id="sec3-0885328211427473"><title>Synthesis of Pluronic/PCL</title>
<p>Pluronic/PCL amphiphilic block copolymers were synthesized by the ring opening polymerization of ε-caprolactone in the presence of PEO-PPO-PEO triblock copolymer (Pluronic) using stannous octoate as the catalyst.<sup><xref ref-type="bibr" rid="bibr23-0885328211427473">23</xref></sup> Calculated amounts of PEO-PPO-PEO triblock copolymer and ε-caprolactone monomer (weight ratio = 1:2) were reacted under nitrogen atmosphere. Stannous octoate (0.5% w/w of total feed stock) was added to catalyze the polymerization reaction. The reaction was heated at 140°C for 12 h. The reaction product was then cooled to room temperature. The obtained viscous material was dissolved in dichloromethane and further precipitated in diethyl ether. The resulting product was filtered and vacuum dried.</p>
</sec>
<sec id="sec4-0885328211427473"><title>Physicochemical characterizations</title>
<sec id="sec5-0885328211427473"><title>Fourier transform infrared spectroscopy</title>
<p>The structure of the synthesized block polymer was characterized by Fourier transform infrared (FTIR) spectra and was recorded using a Thermo Nicolet, 5700 (Germany) spectrometer. The FTIR spectra were obtained in the region 400–4000 cm<sup>−1</sup>.</p>
</sec>
<sec id="sec6-0885328211427473"><title><sup>1</sup>H nuclear magnetic resonance spectroscopy</title>
<p>The<sup>1</sup>H nuclear magnetic resonance (<sup>1</sup>H NMR) spectra of Pluronic/PCL was measured in deuterated chloroform (CDCl<sub>3</sub>) using a 500 MHz spectrometer (Bruker Avance DPX 300). Tetramethylsilane (TMS) was used as the internal standard. The analysis was performed at 22°C and the number of transients during the measurements was set as 16. The relaxation time of the instrument during measurements was 3.17 s. All other parameters were in the default settings of the instrument as per the specifications of Bruker Avance DPX 300.</p>
</sec>
<sec id="sec7-0885328211427473"><title>Gel permeation chromatography</title>
<p>The molecular weight distribution of the block polymer and weight average molecular weight (Mw) was determined by gel permeation chromatography (GPC, Waters HPLC system 600 Series Pump, Milford, United States). Styragel columns-HR-5 E/4E/2/0.5 were used in series. The 2414 refractive index detector and Waters 717 plus autosampler were used. Polystyrene standards used for relative calibration was of peak average molar mass (Mp) 100,000, 34,300, and 1470. The mobile phase was tetrahydrofuran (THF) with a flow-rate of 1 mL/min. The injection volume was usually 100 mL of stock solutions (0.1–0.5 w/v%).</p>
</sec>
<sec id="sec8-0885328211427473"><title>Particle size and zeta potential</title>
<p>The size of the curcumin-loaded micelles was assessed by dynamic light scattering (Nano-ZS 90, Malvern Instrument, United Kingdom). The temperature was kept at 25°C during the measuring process and measurements were recorded as the average of three test runs. The zeta potential of the micellar solutions were measured in folded capillary cells using Nanosizer (Malvern Instrument, United Kingdom). Transmission electron microscope (TEM) experiments were performed on a Hitachi H-7650 (Tokyo, Japan) at an acceleration voltage of 80 kV. Curcumin-loaded micellar suspensions were administered onto a 200 mesh Formvar-coated copper grids and air-dried prior to imaging.</p>
</sec>
<sec id="sec9-0885328211427473"><title>Differential scanning calorimetry</title>
<p>Differential scanning calorimetric (DSC) studies were carried out to define the physical state of curcumin in the carrier and the possibility of any interaction between curcumin and the loaded polymeric matrix. The DSC curves were recorded on a scanning calorimeter equipped with a thermal analysis data system (DSC Q20). Small amounts of the samples were placed in hermetically sealed aluminum pans and heated from 25 to 300°C at a heat flow-rate of 10°C/min under nitrogen spurge.</p>
</sec>
</sec>
<sec id="sec10-0885328211427473"><title>Photophysical characterization</title>
<sec id="sec11-0885328211427473"><title>UV-visible and fluorescence spectroscopy</title>
<p>The photophysical properties of the curcumin-loaded polymeric micelles were analyzed by ultraviolet (UV) spectrometer (Cary model 100 BioUV-Vis spectrophotometer, Varian Australia Pty Ltd, Victoria, Australia). The fluorescence emission spectra of free curcumin and curcumin-loaded polymeric micelles were recorded from 450 to 700 nm with an excitation wavelength of 420 nm on a fluorescence spectrophotometer (Infinite M200, TECAN). The slit widths were set at 5 and 3.5 nm for excitation and emission wavelength, respectively.</p>
</sec>
</sec>
<sec id="sec12-0885328211427473"><title>Determination of block length of Pluronic/PCL</title>
<p>The block length of the PCL (<italic>L</italic><sub>PCL</sub>) was determined from the NMR spectral analysis according to a previously reported calculation.<sup><xref ref-type="bibr" rid="bibr24-0885328211427473">24</xref></sup> The following equation was used for the calculation:
<disp-formula id="disp-formula1-0885328211427473"><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline" id="math1-0885328211427473"><mml:mrow><mml:mtable align="right"><mml:mtr><mml:mtd columnalign="right" columnspan="1"><mml:mrow/></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:mtext>PCL</mml:mtext></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:mtext>Pluronic</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="right" columnspan="1"><mml:mrow/></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mi>   </mml:mi><mml:mo>×</mml:mo><mml:mfrac><mml:mrow><mml:mn>3</mml:mn><mml:mrow><mml:mo/><mml:mo>(</mml:mo></mml:mrow><mml:msub><mml:mrow><mml:mtext>peak</mml:mtext><mml:mo> </mml:mo><mml:mtext>intensity</mml:mtext><mml:mo> </mml:mo><mml:mtext>of</mml:mtext><mml:mo> </mml:mo><mml:mtext>CH</mml:mtext></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mi> </mml:mi><mml:mtext>group</mml:mtext><mml:mo> </mml:mo><mml:mtext>of</mml:mtext><mml:mo> </mml:mo><mml:mtext>PCL</mml:mtext><mml:mrow><mml:mo/><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:mrow><mml:mo/><mml:mo>(</mml:mo></mml:mrow><mml:msub><mml:mrow><mml:mtext>peak</mml:mtext><mml:mo> </mml:mo><mml:mtext>intensity</mml:mtext><mml:mo> </mml:mo><mml:mtext>of</mml:mtext><mml:mo> </mml:mo><mml:mtext>CH</mml:mtext></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub><mml:mi> </mml:mi><mml:mtext>group</mml:mtext><mml:mo> </mml:mo><mml:mtext>in</mml:mtext><mml:mo> </mml:mo><mml:mtext>PPO</mml:mtext><mml:mo> </mml:mo><mml:mtext>of</mml:mtext><mml:mo> </mml:mo><mml:mtext>pluronic</mml:mtext><mml:mrow><mml:mo/><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mfrac><mml:mo>/</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic alternate-form-of="disp-formula1-0885328211427473" xlink:href="10.1177_0885328211427473-eq1.tif"/></disp-formula>
where, <italic>L</italic><sub>Pluronic</sub> is the block length of PPO in Pluronic.</p>
<p>A triblock structure was assumed for the PCL-Pluronic-PCL copolymer and the number-average molecular weight (<italic>M<sub>n</sub></italic>) was computed using the equation below:
<disp-formula id="disp-formula2-0885328211427473"><label>(2)</label><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline" id="math2-0885328211427473"><mml:mrow><mml:msub><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mi> </mml:mi><mml:mtext>of</mml:mtext><mml:mo> </mml:mo><mml:mtext>copolymer</mml:mtext><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mtext> of pluronic</mml:mtext><mml:mo>+</mml:mo><mml:mn>2</mml:mn><mml:msub><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:mtext>PCL</mml:mtext></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mn>114</mml:mn></mml:mrow></mml:math><graphic alternate-form-of="disp-formula2-0885328211427473" xlink:href="10.1177_0885328211427473-eq2.tif"/></disp-formula>
where 114 is the molecular weight of caprolactone (CL) monomer.</p>
</sec>
<sec id="sec13-0885328211427473"><title>Critical micelle concentration</title>
<p>The CMC of the synthesized block polymer was determined by fluorescence spectroscopy using pyrene as fluorescence probe. The fluorescence spectrum was recorded on a fluorescence spectrophotometer (Infinite M200, TECAN). The pyrene solution prepared at a concentration of 6.0 × 10<sup>−7</sup> M in acetone were added to the test tubes and evaporated to remove the solvent. The micellar solutions in deionized water were added to the test tubes in concentrations ranging from 3.9 to 500 µg/mL bringing the final concentration of pyrene to 1.0 × 10<sup>−7</sup> M. The solutions were vortexed and kept overnight at 37°C to equilibrate pyrene with the micelles. At an excitation wavelength of 360 nm, emission spectra of the micelles in pyrene solution were monitored by the spectrofluorometer.</p>
</sec>
<sec id="sec14-0885328211427473"><title>Preparation of curcumin-loaded polymeric micelle by solvent dialysis method</title>
<p>A total of 30 mg Pluronic/PCL was dissolved in 10 mL of dimethylformamide (DMF) solution. To this solution, varying amounts of 3 mg (9.09% w/w), 4 mg (11.76% w/w), 5 mg (14.28% w/w), and 6 mg (16.66% w/w) of curcumin were added and stirred at room temperature. This DMF solution was directly dialyzed for 24 h against 3 L of ultrapure water (resistivity 18.2 Ωm) using cellulose dialysis membranes (molecular weight cutoff: 12 kDa, manufacturer, Sigma). The water was changed three times during the dialysis process. The micellar solution from dialysis bag was collected and centrifuged at 5000 rpm for 15 min to settle the unloaded curcumin. The micellar solution obtained, free from the pelleted curcumin, was frozen at −80°C and then lyophilized using a lyophilizer (Labconco, United States) to obtain a dry powder of curcumin-loaded micellar products for further use.</p>
</sec>
<sec id="sec15-0885328211427473"><title>Curcumin encapsulation</title>
<p>The percentage of encapsulated curcumin was determined by centrifuging the micellar solution, obtained after dialysis, at 5000 rpm for 15 min. The pelleted (unencapsulated) curcumin was dissolved in methanol and was spectrophotometrically quantified using UV spectrometer (Cary model 100 BioUV-Vis spectrophotometer, Varian, Australia) at a wavelength of 430 nm. The encapsulation efficiency was calculated using the following equation:
<disp-formula id="disp-formula3-0885328211427473"><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline" id="math3-0885328211427473"><mml:mrow><mml:mtable align="right"><mml:mtr><mml:mtd columnalign="right" columnspan="1"><mml:mrow/></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mtext>Encapsulation</mml:mtext><mml:mo> </mml:mo><mml:mtext>efficiency</mml:mtext><mml:mrow><mml:mo/></mml:mrow><mml:mi> </mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>%</mml:mi><mml:mrow><mml:mo/><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="right" columnspan="1"><mml:mrow/></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mi>   </mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mtext>Total</mml:mtext><mml:mo> </mml:mo><mml:mtext>amount</mml:mtext><mml:mo> </mml:mo><mml:mtext>of</mml:mtext><mml:mo> </mml:mo><mml:mtext>curcumin</mml:mtext><mml:mo>-</mml:mo><mml:mtext>Free</mml:mtext><mml:mo> </mml:mo><mml:mtext>curcumin</mml:mtext></mml:mrow><mml:mrow><mml:mtext>Total</mml:mtext><mml:mo> </mml:mo><mml:mtext>amount</mml:mtext><mml:mo> </mml:mo><mml:mtext>of</mml:mtext><mml:mo> </mml:mo><mml:mtext>curcumin</mml:mtext></mml:mrow></mml:mfrac><mml:mo>×</mml:mo><mml:mn>1 00</mml:mn><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic alternate-form-of="disp-formula3-0885328211427473" xlink:href="10.1177_0885328211427473-eq3.tif"/></disp-formula>
</p>
</sec>
<sec id="sec16-0885328211427473"><title>In vitro release</title>
<p>Lyophilized curcumin-loaded polymer-conjugated fatty esters were redispersed in 33 mL of 0.01 M PBS solution (pH 7.4) at a formulation concentration of 300 µg/mL. Total volume was divided into 33 eppendorff tubes giving 11 different sets (each set with 3 Eppendorff tubes for the triplicates) for time-dependent release study at time intervals of 2, 4, 6, 12, 24, 36, 48, 60, 72, 96, and 108 h. Free curcumin is completely insoluble in PBS; therefore, at predetermined intervals of time, the solution was centrifuged at 1000 rpm for 5 min to separate the released (pelleted) curcumin from the micelles. At definite time intervals, released amounts of curcumin in loaded micelles were extracted in methanol and quantified at 430 nm using UV-visible spectrophotometer.<sup><xref ref-type="bibr" rid="bibr25-0885328211427473">25</xref></sup> The release was quantified as follows:
<disp-formula id="disp-formula4-0885328211427473"><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline" id="math4-0885328211427473"><mml:mrow><mml:mtext>Release</mml:mtext><mml:mrow><mml:mo/></mml:mrow><mml:mi> </mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>%</mml:mi><mml:mrow><mml:mo/><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mtext>Released</mml:mtext><mml:mo> </mml:mo><mml:mtext>curcumin</mml:mtext></mml:mrow><mml:mrow><mml:mtext>Total</mml:mtext><mml:mo> </mml:mo><mml:mtext>curcumin</mml:mtext></mml:mrow></mml:mfrac><mml:mo>×</mml:mo><mml:mn>1 00</mml:mn><mml:mo>.</mml:mo></mml:mrow></mml:math><graphic alternate-form-of="disp-formula4-0885328211427473" xlink:href="10.1177_0885328211427473-eq4.tif"/></disp-formula>
</p>
</sec>
<sec id="sec17-0885328211427473"><title>Solubility and stability study of curcumin-loaded micelles</title>
<p>Free curcumin and curcumin-loaded Pluronic/PCL particles were dissolved in PBS to observe the aqueous solubility. To study the stability of curcumin in the micelles, free curcumin (dissolved with addition of methanol; final methanol concentration less than 5% volume by volume [v/v]) and the loaded micelles in PBS (0.01 M, pH 7.4) at a concentration of 40 µg/mL (total of 10 mL solution) were incubated in a shaker for 8 h at 37°C with a rotation speed of 150 rpm. A total of 100 µL of sample solutions were taken and added to 900 µL of methanol and quantified spectrophotometrically at 430 nm.</p>
</sec>
<sec id="sec18-0885328211427473"><title>Electrophoresis analysis of polymer–plasma protein interactions</title>
<p>Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS PAGE) analysis was performed to detect the interaction of Pluronic/PCL copolymers with plasma proteins. Pluronic/PCL copolymers were incubated with human plasma (diluted with saline) for 1 h at 37°C. The samples were then centrifuged at 10,000 rpm for 10 min and 20 µL of the supernatant was loaded on 7% resolving and 4% stacking gel at 100 V for 90 min using Mini-PROTEAN II electrophoresis system (Bio-Rad, CA, United States). The gel was stained with coomassie blue and documented using an image analyzer (LAS 4000, Fuji). Plasma incubated with normal saline (0.09% sodium chloride [NaCl]) was considered as the control.</p>
</sec>
<sec id="sec19-0885328211427473"><title>Blood compatibility study</title>
<sec id="sec20-0885328211427473"><title>Hemolysis</title>
<p>For performing the hemolysis and aggregation studies, the human blood sample was collected in a tube containing 3.8% sodium citrate at ratio 9:1 (blood:anticoagulant). A total of 200 µL of blood was mixed with 800 µL of saline and was centrifuged at 750 rpm for 10 min. The erythrocytes obtained after repeated washings (plasma-free) were resuspended in fresh saline and vortexed. A total of 100 µL of the pellet was added to the empty and curcumin-loaded micellar solutions, which were kept for incubation at 37°C for 2 h. The absorbances were measured at 541 nm. Normal saline was used as negative control and distilled water as positive control.<sup><xref ref-type="bibr" rid="bibr26-0885328211427473">26</xref></sup> Percentage of hemolysis was calculated using the following equation:
<disp-formula id="disp-formula5-0885328211427473"><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline" id="math5-0885328211427473"><mml:mrow><mml:mtable align="right"><mml:mtr><mml:mtd columnalign="right" columnspan="1"><mml:mrow/></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mtext>Percentage of hemolysis</mml:mtext></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="right" columnspan="1"><mml:mrow/></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mi>   </mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mtext>OD of test solution</mml:mtext><mml:mo>-</mml:mo><mml:mtext>OD of negative control</mml:mtext></mml:mrow><mml:mrow><mml:mtext>OD of positive control</mml:mtext><mml:mo>-</mml:mo><mml:mtext>OD of negative control</mml:mtext></mml:mrow></mml:mfrac></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic alternate-form-of="disp-formula5-0885328211427473" xlink:href="10.1177_0885328211427473-eq5.tif"/></disp-formula>
where OD refers to optical density.</p>
</sec>
<sec id="sec21-0885328211427473"><title>Red blood cell aggregation</title>
<p>Human erythrocytes were collected by centrifugation of whole blood at 700 rpm for 10 min and then diluted with saline at 1:10 ratio. To 100 µL of erythrocytes, 100 µL curcumin-loaded and unloaded micelles were added and incubated for 1 h at 37°C. Normal saline (0.09% NaCl) and polyethylenimine (PEI) were used as the negative and positive controls, respectively.<sup><xref ref-type="bibr" rid="bibr27-0885328211427473">27</xref></sup> After incubation, the cells were isolated by centrifugation and the aggregation images were captured on a phase contrast microscope (Leica DM IRB, Germany).</p>
</sec>
<sec id="sec22-0885328211427473"><title>White blood cell aggregation</title>
<p>The white blood cell (WBC) compatibility study was done with anticoagulated blood (1 mL) overlaid with histopaque (1 mL) in order to make three separate layers and was centrifuged for 15 min at 800 rpm at room temperature. The collected WBC was incubated with the micelles for 1 h at 37 °C. Aggregation was detected through phase contrast microscope (Leica DM IRB, Germany).</p>
</sec>
<sec id="sec23-0885328211427473"><title>Platelet aggregation</title>
<p>The platelet layer was isolated from the anticoagulated blood overlaid with histopaque and the platelets were incubated with micelles at 37°C for 1 h. Detection of aggregation was done through phase contrast microscope (Leica DM IRB, Germany).</p>
</sec>
</sec>
<sec id="sec24-0885328211427473"><title>Cytotoxicity studies – MTT assay</title>
<p>In order to check the cytotoxicities of various concentrations of curcumin-loaded polymeric micelles, MTT assay was done on Caco2 cell lines. These cells were seeded in culture flasks with DMEM medium along with 10% FBS and incubated for 24 h at 37°C in 5% CO<sub>2</sub> and 95% humidity to attain a cell growth of 80% confluency. Prior to the experiment, the cells were trypsinized and transferred to a 24-well cell culture plate at a density of 1 × 10<sup>5</sup>cells/well. Dimethylsulfoxide (DMSO) was added to aid the solubility of curcumin in aqueous media. The final concentration of DMSO in the culture medium was ensured to be less than 0.1%. The cells were exposed to a series of different concentrations of free and encapsulated curcumin (2.5–20 µM) for 48 h followed by addition of 100 µL MTT (0.5 mg/mL) and incubated for 3 h at 37°C. Formazan crystals formed were dissolved with the addition 300 µL of DMSO per well. An incubation period of 15 min at 37°C was provided. The absorbance was measured at 570 nm using a plate reader (Finstruments Micro plate Reader, United States). The cells treated with medium were used as negative control. Cytotoxicity of the unloaded micelles were also assessed in the similar manner. The percentage viability was calculated as:
<disp-formula id="disp-formula6-0885328211427473"><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline" id="math6-0885328211427473"><mml:mrow><mml:mtext>Cell</mml:mtext><mml:mo> </mml:mo><mml:mtext>viability</mml:mtext><mml:mrow><mml:mo/></mml:mrow><mml:mi> </mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>%</mml:mi><mml:mrow><mml:mo/><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mtext>Nt</mml:mtext><mml:mo>/</mml:mo><mml:mtext>Nc</mml:mtext><mml:mo>×</mml:mo><mml:mn>1 00</mml:mn></mml:mrow></mml:math><graphic alternate-form-of="disp-formula6-0885328211427473" xlink:href="10.1177_0885328211427473-eq6.tif"/></disp-formula>
where Nt was the absorbance of the cells treated with free curcumin or curcumin-loaded micelles and Nc was the absorbance of the untreated cells.</p>
</sec>
<sec id="sec25-0885328211427473"><title>Cellular uptake studies – fluorescence microscopy</title>
<p>The Caco2 cells were grown in 35 mm culture plate up to 80% confluency to visualize the cellular uptake of curcumin-loaded micelles. The molar concentration of curcumin used for the uptake study was 10 µM. All the samples were dissolved in PBS (0.01 M, pH 7.4) and as free curcumin was insoluble in aqueous solution, it was dissolved with the aid of DMSO and then diluted with PBS. Cells were treated with free curcumin and curcumin-loaded micelles. They were incubated for 4 h prior to viewing under a fluorescence microscope (Leica DMI3000) for intracellular curcumin fluorescence.</p>
</sec>
<sec id="sec26-0885328211427473"><title>Statistical analysis</title>
<p>Data are represented as mean ± standard deviation (SD) of three independent experiments. Statistical analysis of the data was performed via one-way analysis of variance (ANOVA) using SPSS software (SPSS-16, IBM, USA); a value of <italic>p</italic> &lt; 0.05 was considered significant (<italic>n</italic> = 3).</p>
</sec>
<sec id="sec27-0885328211427473" sec-type="results"><title>Results and discussion</title>
<sec id="sec28-0885328211427473"><title>Synthesis and characterization of curcumin-loaded polymeric micelles</title>
<p>Stannous octoate due to its low cost and high efficiency was the catalyst of choice for lactone polymerization. Stannous octoate-mediated ring-opening polymerization of ε-caprolactone and Pluronic afforded the formation of Pluronic/PCL block copolymer. <xref ref-type="fig" rid="fig1-0885328211427473">Figure 1</xref> represents the reaction scheme for the synthesis. The mechanism involved the metal species functioning as a catalyst and the end hydroxyl group of the Pluronic serving as an initiator. The active hydrogen atom at one end of the Pluronic chain acted as an initiator and induced a selective acyl-oxygen cleavage of ε-caprolactone. A strong carbonyl band at 1736 cm<sup>−1</sup> indicated the formation of Pluronic/PCL block copolymer (<xref ref-type="fig" rid="fig2-0885328211427473">Figure 2(a)</xref>). No significant difference was observed in the spectral pattern for the different sets of Pluronics. Bands at 2943 and 2865 cm<sup>−1</sup> were also observed and was believed to occur due to the overlapping of the aliphatic CH stretching band of PCL and Pluronic, respectively.<sup><xref ref-type="bibr" rid="bibr24-0885328211427473">24</xref></sup> Absence of the OH stretching peak of curcumin at 3505 cm<sup>−1</sup> (IR spectrum of curcumin not shown) and a shift in the C = O absorption of the loaded Pluronic/PCL to a lower wave number (1723 cm<sup>−1</sup>), which was attributed to the formation of intermolecular hydrogen bonds between the hydroxyl group of curcumin and the carbonyl group of the copolymer, suggested the encapsulation of curcumin(<xref ref-type="fig" rid="fig2-0885328211427473">Figure 2(b)</xref>).<sup><xref ref-type="bibr" rid="bibr28-0885328211427473">28</xref></sup> The<sup>1</sup>H NMR spectra showed a sharp singlet at ∼3.63 ppm due to the protons of CH<sub>2</sub>CH<sub>2</sub> units of PEO. The doublet at 1.129 ppm corresponded to CH<sub>3</sub> protons in PPO. The CH and CH<sub>2</sub> units of PPO were depicted by the peaks at ∼3.39 and 3.5 ppm. Two intense triplets at 4.05 and 2.30 ppm were observed in addition to the multiplets at ∼1.4 and 1.6 ppm, which were attributed to the PCL block (<xref ref-type="fig" rid="fig3-0885328211427473">Figure 3</xref>). Our spectral analysis was in accordance with the<sup>1</sup>H NMR characterization of Pluronic/PCL in a previously reported work.<sup><xref ref-type="bibr" rid="bibr24-0885328211427473">24</xref></sup> The average molecular weight (Mw) of the copolymer using the<sup>1</sup>H NMR data and applying the Equations (1) and (2) was 28,201. The <italic>L</italic><sub>PCL</sub> in Pluronic/PCL was calculated as 68.34. The molecular weight obtained from GPC was 26,663 with a polydispersity index of 1.66. Formation of a tri-block structure was confirmed from the similar values in the molecular weights obtained from NMR and GPC analysis.
<fig id="fig1-0885328211427473" position="float"><label>Figure 1.</label><caption><p>Reaction scheme for the ring opening polymerization of ε-caprolactone and Pluronic using stannous octoate as catalyst.</p></caption><graphic xlink:href="10.1177_0885328211427473-fig1.tif"/>
</fig>
<fig id="fig2-0885328211427473" position="float"><label>Figure 2.</label><caption><p>Infra red (IR) spectrum. (a) Pluronic/PCL and (b) curcumin-loaded Pluronic/PCL.</p></caption><graphic xlink:href="10.1177_0885328211427473-fig2.tif"/>
</fig>
<fig id="fig3-0885328211427473" position="float"><label>Figure 3.</label><caption><p>The<sup>1</sup>H nuclear magnetic resonance (<sup>1</sup>H NMR) spectrum of Pluronic/PCL.</p></caption><graphic xlink:href="10.1177_0885328211427473-fig3.tif"/>
</fig></p>
</sec>
</sec>
<sec id="sec29-0885328211427473"><title>CMC of Pluronic/PCL copolymers</title>
<p>Application of pyrene as a fluorescence probe, based on changes in the intensity of the vibrational bands of pyrene, is a widely used methodology for determining the CMC. The relative peak intensity of pyrene undergoes significant perturbation upon transition from polar to nonpolar solvents. The ratio of the fluorescence intensity of the first vibrational band (370 nm), the highest energy vibrational band, to that of the third vibrational band (402 nm) has been shown to correlate with solvent polarity.<sup><xref ref-type="bibr" rid="bibr29-0885328211427473">29</xref></sup> In polar environment, pyrene behaves as a self-quenching agent but exhibits fluorescence when located in the proximity of hydrophopic domain of a micelle.</p>
<p>The Pluronic/PCL block copolymer arranged into its micellar form in aqueous medium forcing pyrene molecules to move into the micelles from the aqueous phase. This transition altered the intensity ratio of (I<sub>370</sub>/I<sub>402</sub>) of pyrene fluorescence bands. It was also observed that with increased polymer concentrations, the intensity also increased as pyrene was shifted to the hydrophobic interior. The CMC value was measured from the point of inflection of the sigmoid curve (<xref ref-type="fig" rid="fig4-0885328211427473">Figure 4</xref>). The CMC value calculated for Pluronic/PCL was 4.2 × 10<sup>−7</sup> M. A high CMC value of Pluronic block copolymers limits their applications in drug delivery.<sup><xref ref-type="bibr" rid="bibr30-0885328211427473">30</xref></sup> Incorporation of PCL afforded a lower CMC value, which signified enhanced hydrophobicity that enabled the easy micelle formation of Pluronic/PCL. This indicated that the micelles may be useful as drug carriers as they could maintain a micelle structure even upon dilution with a large volume of blood.
<fig id="fig4-0885328211427473" position="float"><label>Figure 4.</label><caption><p>Critical micelle concentration (CMC) measurement by using pyrene as a fluorescence probe.</p></caption><graphic xlink:href="10.1177_0885328211427473-fig4.tif"/>
</fig></p>
</sec>
<sec id="sec30-0885328211427473"><title>Curcumin loading and encapsulation efficiency</title>
<p>Curcumin-loaded Pluronic/PCL micelles were prepared by dialysis method. The dialysis method consists in bringing the drug and copolymer from organic solvent in which they are both soluble to a solvent that is selective only for the hydrophilic part of the polymer (e.g., water). As the organic solvent is replaced by the selective one, the hydrophobic portion of the polymer associates to form the micellar core incorporating the insoluble drug during the process. Curcumin was loaded into the inner hydrophobic core of the Pluronic/PCL micelles by adopting similar strategy.</p>
<p>The loading efficiency of curcumin is a factor which gets compromised despite high encapsulation efficiency. Curcumin delivery in self-assembling methoxy poly (ethylene glycol)–palmitate nanocarrier of Sahu et al. exhibited loading efficiency of 1% despite an encapsulation close to 100%.<sup>17</sup> We carried out curcumin loading in Pluronic/PCL micelles at 9.09, 11.76, and 14.28% w/w, which afforded an encapsulation efficiency of 96.59 ± 1.01, 87.03 ± 2.21, and 72.08 ± 4.29%, respectively. This corresponded to an actual loading of 8.781 ± 0.09, 10.224 ± 0.26, and 10.29 ± 0.61% w/w. Precipitation of curcumin was observed when 16.66% w/w loading was performed, and hence, theoretical loading of 14.28% w/w was chosen as the optimized loading efficiency for further in vitro studies. Mohanty et al. performed a 9% w/w theoretical curcumin loading with 57% encapsulation efficiency with methoxy polyethylene glycol (mPEG)/PCL di-block copolymeric micelles.<sup><xref ref-type="bibr" rid="bibr31-0885328211427473">31</xref></sup> Incorporation of Pluronic in our study showed an improvement in the loading efficiency of curcumin compared to the mPEG/PCL micelles. We could attain an encapsulation efficiency of 72% with 14% w/w theoretical curcumin loading. This could be attributed to the presence of propylene oxide moieties in the Pluronic, which were capable of enhancing the hydrophobicity of the micellar core thereby increasing the curcumin encapsulation.</p>
</sec>
<sec id="sec31-0885328211427473"><title>Particle size and zeta potential measurement</title>
<p>Particle size is an important parameter as it can directly affect the physical stability, cellular uptake, biodistribution, and drug release from the nanoparticles.<sup><xref ref-type="bibr" rid="bibr32-0885328211427473">32</xref></sup> The particle sizes of the unloaded Pluronic/PCL micelles determined by dynamic light scattering (DLS) are shown in <xref ref-type="table" rid="table1-0885328211427473">Table 1</xref>. Encapsulation of curcumin was evident from the gradual increase in the size of micelles with the increased curcumin loading. <xref ref-type="fig" rid="fig5-0885328211427473">Figure 5</xref> depicts the TEM image of curcumin-loaded Pluronic/PCL (14% w/w). The size of the micelles observed in the TEM image were smaller than that obtained in DLS and the reason could be attributed to the shrinkage of the hydrophilic backbone during the sample preparation for TEM.
<fig id="fig5-0885328211427473" position="float"><label>Figure 5.</label><caption><p>Transmission electron microscope (TEM) image of curcumin-loaded Pluronic/PCL micelles.</p></caption><graphic xlink:href="10.1177_0885328211427473-fig5.tif"/>
</fig>
<table-wrap id="table1-0885328211427473" position="float"><label>Table 1.</label><caption><p>Effect of curcumin-loading on Pluronic/PCL micelles.</p></caption>
<graphic alternate-form-of="table1-0885328211427473" xlink:href="10.1177_0885328211427473-table1.tif"/>
<table frame="hsides"><thead align="left">
<tr><th>Theoretical loading efficiency (%)</th>
<th>Particle size (nm)</th>
<th>Zeta potential (mV)</th>
</tr></thead>
<tbody align="left">
<tr>
<td>0</td>
<td>59.20 ± 0.6</td>
<td>−14.6 ± 1.2</td>
</tr>
<tr>
<td>9.09</td>
<td>88.4 ± 0.9</td>
<td>−16.5 ± 0.2</td>
</tr>
<tr>
<td>11.75</td>
<td>159.9 ± 3.3</td>
<td>−15.4 ± 0.5</td>
</tr>
<tr>
<td>14.28</td>
<td>195.7 ± 7.3</td>
<td>−17.6 ± 0.4</td>
</tr>
</tbody>
</table>
</table-wrap></p>
<p>Information regarding a charged active material being encapsulated within the centre of the nanocapsule or adsorbed onto the surface can be gathered by zeta potential determination.<sup><xref ref-type="bibr" rid="bibr33-0885328211427473">33</xref></sup> The micelles had a zeta potential in the range of −14 to −17 mV (<xref ref-type="table" rid="table1-0885328211427473">Table 1</xref>). Negligible change in the zeta potential indicated that curcumin was encapsulated inside the Pluronic/PCL micelles. Nanoparticles with a zeta potential above ±30 mV have been shown to be stable in suspension, as the surface charge prevents aggregation of the particles. The optimum zeta potential value of the curcumin-loaded micelles explained its stability in aqueous medium.</p>
</sec>
<sec id="sec32-0885328211427473"><title>Curcumin–copolymer interactions</title>
<p>The DSC is an accurate and rapid thermoanalytical technique, widely used by the pharmaceutical industry and in drug research, to investigate several physicochemical phenomena, such as polymorphism, melting and crystallization, purity, drug–excipient interaction, polymer properties, and so on.<sup><xref ref-type="bibr" rid="bibr34-0885328211427473">34</xref></sup> The physical status of curcumin encapsulated in the polymeric micelles was investigated by DSC. Free curcumin has an endothermic melting peak at 177.18°C implying its crystalline state.<sup><xref ref-type="bibr" rid="bibr35-0885328211427473">35</xref></sup> This peak was absent in the thermogram of curcumin-loaded Pluronic/PCL copolymers, which only exhibited the characteristic melting peaks of Pluronic/PCLs around 57°C (<xref ref-type="fig" rid="fig6-0885328211427473">Figure 6 (a)</xref> and (<xref ref-type="fig" rid="fig6-0885328211427473">b</xref>)). The absence of detectable crystalline domains of curcumin in the loaded micelles indicated that encapsulated curcumin was in the amorphous form in the polymeric matrix.<sup><xref ref-type="bibr" rid="bibr36-0885328211427473">36</xref></sup> The presence of drug in crystalline form inside nanoparticles can pose as an obstacle due to the difficulty in the diffusion of the large-sized molecules from the small pores of the nanoparticles. However, a sustained release of the encapsulated drug is possible if the drug is in amorphous phase, as it facilitates easy diffusion of drug molecules through the polymeric matrix.
<fig id="fig6-0885328211427473" position="float"><label>Figure 6.</label><caption><p>Differential scanning calorimetry (DSC) thermogram of (a) curcumin and (b) curcumin-loaded Pluronic/PCL.</p></caption><graphic xlink:href="10.1177_0885328211427473-fig6.tif"/>
</fig></p>
</sec>
<sec id="sec33-0885328211427473"><title>Photophysical characterization</title>
<p>Encapsulation of curcumin in the micelles was further confirmed by photophysical characterization studies. Distinct photophysical properties were exhibited by the curcumin-loaded micelles. Curcumin, solubilized in 10% methanolic solution, showed an absorption peak at 425 nm. Similar peak with a decrease in absorption intensity was exhibited by curcumin-loaded Pluronic/PCL micelles (<xref ref-type="fig" rid="fig7-0885328211427473">Figure 7</xref>). In the fluorescence spectra, curcumin showed a weak broad peak at 550 nm and the curcumin-loaded Pluronic/PCL micelles showed a well-defined high-intensity blue-shifted fluorescent peak at 495 nm (<xref ref-type="fig" rid="fig8-0885328211427473">Figure 8</xref>). This suggested the binding of curcumin to the hydrophobic core of the micelles.<sup><xref ref-type="bibr" rid="bibr37-0885328211427473">37</xref></sup> Recent report by Sahu et al. explained the shift in fluorescence spectra of curcumin-encapsulated bovine casein micelle, from 540 to 500 nm, due to the binding of curcumin in the hydrophobic domain of the protein molecule in micelle.<sup><xref ref-type="bibr" rid="bibr16-0885328211427473">16</xref></sup>
<fig id="fig7-0885328211427473" position="float"><label>Figure 7.</label><caption><p>Ultra violet (UV)-visible absorption spectrum. (a) Curcumin in 10% methanolic solution and (b) curcumin-loaded Pluronic/PCL micelles.</p></caption><graphic xlink:href="10.1177_0885328211427473-fig7.tif"/>
</fig>
<fig id="fig8-0885328211427473" position="float"><label>Figure 8.</label><caption><p>Fluorescence emission spectrum. (a) Curcumin-loaded Pluronic/PCL micelles and (b) curcumin in 10% methanolic solution.</p></caption><graphic xlink:href="10.1177_0885328211427473-fig8.tif"/>
</fig></p>
</sec>
<sec id="sec34-0885328211427473"><title>Interaction with plasma proteins</title>
<p>Understanding nanoparticle–protein interaction is a prominent factor, which helps in promoting applications of nanoparticles in the biomedical fields and reducing/preventing possible adverse effects to the biological systems caused by nanoparticles. The binding extent of plasma proteins with Pluronic/PCL micelles was examined by performing SDS PAGE (<xref ref-type="fig" rid="fig9-0885328211427473">Figure 9</xref>). Lanes 2 and 3 corresponded to Pluronic/PCL and curcumin-loaded Pluronic/PCL, respectively. It was observed that the protein bands corresponding to most of the low molecular weight globular proteins were present in all the polymer–plasma samples. The protein bands were similar to the band obtained in Lane 1, which corresponded to normal saline indicating that the micelles did not bind with the plasma proteins. Surface induced thrombosis, which is one of the major problems in the clinical application of blood-contacting materials, begins with adsorption of plasma proteins to the surface.<sup><xref ref-type="bibr" rid="bibr38-0885328211427473">38</xref>,<xref ref-type="bibr" rid="bibr39-0885328211427473">39</xref></sup> The lack of adherence of plasma proteins on the Pluronic/PCL micelles could be attributed to the PEO units in Pluronic, which are capable of prohibiting adsorption of proteins and cells depending on the surface density of PEO chains, their length, and dynamics.<sup><xref ref-type="bibr" rid="bibr40-0885328211427473">40</xref></sup> The biodistribution of the carrier is mainly dictated by the nature of the hydrophilic shell, which is responsible for micelle stabilization and interactions with plasma proteins and cell membranes.<sup><xref ref-type="bibr" rid="bibr41-0885328211427473">41</xref></sup>
<fig id="fig9-0885328211427473" position="float"><label>Figure 9.</label><caption><p>Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS PAGE) showing the interactions of micelles with the plasma proteins. Lanes 2 and 3 corresponds to empty and curcumin-loaded Pluronic/PCL micelles, respectively. Lane 1 is the control performed with saline.</p></caption><graphic xlink:href="10.1177_0885328211427473-fig9.tif"/>
</fig></p>
</sec>
<sec id="sec35-0885328211427473"><title>Hemolysis study</title>
<p>Hemocompatibility is a significant parameter to evaluate the responses that arises between drug carrier and blood, and it determines the safety parameter of the material in the human body. Plasma hemoglobin assay can be classified as direct optical technique, that is, quantification based on oxyhemoglobin’s absorbance peak.<sup><xref ref-type="bibr" rid="bibr42-0885328211427473">42</xref></sup> Oxyhemoglobin has strong absorption peak at 541 nm. Oxyhemoglobin will leak out from the lysed red blood cells (RBCs) and correspondingly high-intensity absorption peak would be obtained at 541 nm. For materials that do not induce hemolysis, this peak would be negligible.<sup><xref ref-type="bibr" rid="bibr43-0885328211427473">43</xref></sup></p>
<p>Negligible percentage (less than 1%) of hemolysis was observed in the case of empty and curcumin-loaded micelles, which indicated that the synthesized nanoparticles were compatible with the erythrocytes (<xref ref-type="table" rid="table2-0885328211427473">Table 2</xref>). This was an expected observation as both the components of the micelles, Pluronic, and PCL are widely used matrices for biological applications. Curcumin’s ability to induce apoptosis in cancer cells without cytotoxic effects on healthy cells is well documented in the literature.<sup><xref ref-type="bibr" rid="bibr44-0885328211427473">44</xref></sup> The blood compatibility of the micelles was further visually revealed through aggregation studies.
<table-wrap id="table2-0885328211427473" position="float"><label>Table 2.</label><caption><p>Hemolysis results.</p></caption>
<graphic alternate-form-of="table2-0885328211427473" xlink:href="10.1177_0885328211427473-table2.tif"/>
<table frame="hsides"><thead align="left">
<tr><th>Sample</th>
<th>Hemolysis (%)</th>
</tr></thead>
<tbody align="left">
<tr>
<td>Pluronic127/PCL</td>
<td>0.0722 ± 0.003</td>
</tr>
<tr>
<td>Curcumin-loaded Pluronic/PCL</td>
<td>0.0765 ± 0.023</td>
</tr>
<tr>
<td>Saline (negative control)</td>
<td>0</td>
</tr>
<tr>
<td>Distilled water (positive control)</td>
<td>100</td>
</tr>
</tbody>
</table>
</table-wrap></p>
</sec>
<sec id="sec36-0885328211427473"><title>RBC, WBC, and platelet aggregation</title>
<p>Blood cell aggregation is a highly undesirable phenomenon that can induce serious circulatory disorders, even lethal toxicity. Evaluation of blood compatibility is essential for materials developed for biological applications. Negligible aggregation was detected in RBC, WBC, and platelets incubated with the micelles indicating the nontoxic effect of the micelles on normal cells. The micrographs of human blood cells (RBC, WBC, and platelets) upon interaction with the loaded and unloaded micelles along with normal saline and PEI as controls are shown in <xref ref-type="fig" rid="fig10-0885328211427473">Figures 10</xref>–<xref ref-type="fig" rid="fig12-0885328211427473">12</xref>. It was observed that the micelles did not promote aggregation like the positive control, PEI. Positive controls in blood studies are materials that induce aggregation of the blood cells. The PEI is a cationic polymer and is reported to have strong toxicity and is often used as a positive control in blood aggregation studies.<sup><xref ref-type="bibr" rid="bibr45-0885328211427473">45</xref></sup> The nonaggregation of the micelles could be attributed to the Pluronic moiety. The use of Pluronic for modifying blood compatibility of materials is well documented in the literature and the improved antithrombogenicity of Pluronic can be attributed to the long polyethylene oxide chains, which are capable of suppressing blood cell adhesion.<sup><xref ref-type="bibr" rid="bibr46-0885328211427473">46</xref></sup>
<fig id="fig10-0885328211427473" position="float"><label>Figure 10.</label><caption><p>Red blood cell (RBC) aggregation in (A) saline, (B) PEI, (C) Pluronic/PCL micelles, and (D) curcumin-loaded Pluronic/PCL micelles.</p></caption><graphic xlink:href="10.1177_0885328211427473-fig10.tif"/>
</fig>
<fig id="fig11-0885328211427473" position="float"><label>Figure 11.</label><caption><p>White blood cell (WBC) aggregation in (A) saline, (B) PEI, (C) Pluronic/PCL micelles, and (D) curcumin-loaded Pluronic/PCL micelles.</p></caption><graphic xlink:href="10.1177_0885328211427473-fig11.tif"/></fig>
<fig id="fig12-0885328211427473" position="float"><label>Figure 12.</label><caption><p>Platelet aggregation in (A) saline, (B) PEI, (C) Pluronic/PCL micelles, and (D) curcumin-loaded Pluronic/PCL micelles.</p></caption><graphic xlink:href="10.1177_0885328211427473-fig12.tif"/>
</fig></p>
</sec>
<sec id="sec37-0885328211427473"><title>Solubility and stability of curcumin-loaded Pluronic/PCL micelles</title>
<p>Free curcumin was found to be sparingly soluble in aqueous solution with formation of visible undissolved microscopic flakes compared to the curcumin-loaded micellar solution (<xref ref-type="fig" rid="fig13-0885328211427473">Figure 13</xref>). Instability and biodegradation in physiological pH are the major challenges faced by curcumin. Degradation of curcumin in aqueous solution has been attributed to hydrolysis and Wang et al. have reported the rapid hydrolytic degradation to occur above neutral pH.<sup><xref ref-type="bibr" rid="bibr47-0885328211427473">47</xref></sup> Partially deprotonated curcumin is transformed into trans-6 -(4′-hydroxy-3′-methoxyphenyl)−2,4-dioxo-5-hexenal upon fragmentation, which is further degraded to vanillin, feruloyl methane, and ferulic acid. The contribution of these molecules toward light absorption is negligible.<sup><xref ref-type="bibr" rid="bibr48-0885328211427473">48</xref></sup> This implied that a decrease in absorbance, while monitoring the degradation of curcumin, is due to the proportional decrease in the curcumin concentration. We attempted to study the biodegradation and stability of curcumin by incubating both free and encapsulated curcumin in PBS and estimated its concentration with time, spectrophotometrically. It was observed that only 5% of free curcumin remained intact after an incubation of 8 h, whereas 94% of curcumin encapsulated in the Pluronic/PCL micelles remained intact (<xref ref-type="fig" rid="fig14-0885328211427473">Figure 14</xref>). Curcumin, due to its hydrophibicity, was presumed to be inside the core of the micelles and the copolymeric micelles were capable of protecting the encapsulated curcumin against biotransformation and hydrolysis.
<fig id="fig13-0885328211427473" position="float"><label>Figure 13.</label><caption><p>Solubility study. (A) Free curcumin was insoluble in aqueous medium and (B) curcumin encapsulated in Pluronic/PCL micelles exhibited enhanced solubility.</p></caption><graphic xlink:href="10.1177_0885328211427473-fig13.tif"/>
</fig>
<fig id="fig14-0885328211427473" position="float"><label>Figure 14.</label><caption><p>Stability of curcumin in phosphate-buffered saline (PBS; 0.01 M, pH 7.4) at 37°C. Values reported are mean ± standard deviation (SD), <italic>n</italic> = 3.</p></caption><graphic xlink:href="10.1177_0885328211427473-fig14.tif"/>
</fig></p>
</sec>
<sec id="sec38-0885328211427473"><title>In vitro release</title>
<p>A sustained release of curcumin was expected from DSC results based on the amorphous nature of curcumin in the Pluronic/PCL matrix and this was further confirmed by the in vitro release study. The curcumin release profile from the Pluronic/PCL micelles is pictured in <xref ref-type="fig" rid="fig15-0885328211427473">Figure 15</xref>. After 108 h, 60.11 ± 2.6% of curcumin were released from Pluronic/PCL, respectively. The expected sustained release was observed after 20 h from the matrix. As evident from the <italic>in vitro release</italic> profile, curcumin-loaded Pluronic/PCL micelles may have the potential to serve as a sustained release matrix, since such drug delivery systems are much sought after for its less frequent administration leading to patient compliance.
<fig id="fig15-0885328211427473" position="float"><label>Figure 15.</label><caption><p>In vitro release from curcumin-loaded Pluronic/PCL micelles at pH 7.4. Error bars represent means ± standard deviation (SD) for <italic>n</italic> = 3.</p></caption><graphic xlink:href="10.1177_0885328211427473-fig15.tif"/>
</fig></p>
</sec>
<sec id="sec39-0885328211427473"><title>Cytotoxicity studies – MTT assay</title>
<p>The MTT assay was performed on the empty and curcumin-loaded micelles. It was observed that Pluronic/PCL micelles did not exhibit any toxicity, which was in accordance with the hemolytic study. In all 100% cell viability was encountered at 3 mg/mL copolymer concentration (<xref ref-type="fig" rid="fig16-0885328211427473">Figure 16(a)</xref>). The potential of curcumin to elicit apoptosis signals in a variety of tumor tissues, including colorectal, lung breast, pancreatic, and prostate carcinoma, is well documented in the literature.<sup><xref ref-type="bibr" rid="bibr49-0885328211427473">49</xref>,<xref ref-type="bibr" rid="bibr50-0885328211427473">50</xref></sup> Levi-Ari et al. have suggested that curcumin’s apoptotic ability is related to the inhibition of the activation of mitogen-activated protein kinase, which subsequently downregulates the expression of cyclooxygenase (COX-2).<sup><xref ref-type="bibr" rid="bibr51-0885328211427473">51</xref>,<xref ref-type="bibr" rid="bibr52-0885328211427473">52</xref></sup> Inadequate water solubility and subsequent precipitation decreased the effective exposure time of the cells with free curcumin leading to relatively less cytotoxicity compared to the curcumin-loaded micelles (<xref ref-type="fig" rid="fig16-0885328211427473">Figure 16(b)</xref>). Less than 60% cells were viable at a curcumin concentration of 10 μM in the curcumin-loaded micelles. Low cell viability of Caco2 cells was attributed to the enhanced aqueous solubility and effective cell internalization of the curcumin-loaded Pluronic/PCL micelles. Enhanced cytotoxicity could also be attributed to the presence of Pluronic. Yan et al. recently observed that the docetaxel-loaded Poly[lactic-co-glycolic acid] (PLGA)/poloxamer 188 nanoparticles achieved a significantly higher level of cytotoxicity than that of docetaxel-loaded PLGA nanoparticles and Taxotere.<sup><xref ref-type="bibr" rid="bibr53-0885328211427473">53</xref></sup> Similar observation had been reported by Mei et al. with docetaxel-loaded PCL/Pluronic F68 nanoparticles in docetaxel-resistant human breast cancer cell line, MCF-7 TAX30.<sup><xref ref-type="bibr" rid="bibr54-0885328211427473">54</xref></sup> Our cytotoxicity study affirmed that the transition of crystalline phase of curcumin to the amorphous state upon encapsulation did not hinder its anticancer potential and that the micellar encapsulation did not compromise curcumin’s therapeutic activity.
<fig id="fig16-0885328211427473" position="float"><label>Figure 16.</label><caption><p>(a) Cytotoxicity study of empty Pluronic/PCL micelles on colorectal adenocarcinoma (Caco2) cells. Values reported are mean ± standard deviation (SD), <italic>n</italic> = 3. (b) Cytotoxicity study of curcumin-loaded Pluronic/PCL micelles in Caco2 cells compared to the native form. Significant difference was observed between control vs all concentrations of curcumin and curcumin-loaded micelles. There was significant difference between curcumin and curcumin-loaded micelles from concentration of 10 µM and above. Statistically significant difference (<italic>p</italic> &lt; 0.05) is denoted by *. Values exhibited are mean ± SD, <italic>n</italic> = 3.</p></caption><graphic xlink:href="10.1177_0885328211427473-fig16.tif"/>
</fig></p>
</sec>
<sec id="sec40-0885328211427473"><title>Cellular uptake study</title>
<p>Green intrinsic fluorescence of curcumin is a widely exploited factor in the cellular uptake studies of curcumin. Curcumin has the advantage to be traced inside cells without being tagged by other fluorescent dyes. We confirmed the cellular internalization of curcumin-loaded Pluronic/PCL micelles by fluorescence microscopy in Caco2 cells. The empty copolymeric micelles did not exhibit any fluorescence (<xref ref-type="fig" rid="fig17-0885328211427473">Figure 17(a)</xref>). Curcumin-loaded micelles showed intracellular green fluorescence proving that the Caco2 cells efficiently took up the micelles compared to the free curcumin. However, entry of free curcumin was not prominent in the cells owing to its low aqueous solubility (<xref ref-type="fig" rid="fig17-0885328211427473">Figure 17(b)</xref> and (<xref ref-type="fig" rid="fig17-0885328211427473">c</xref>)). Similar observations on the effect of curcumin-encapsulated Pluronic micelles in HeLa cells have been reported by Sahu et al.<sup><xref ref-type="bibr" rid="bibr22-0885328211427473">22</xref></sup> Micelles with Pluronic moiety have been known to undergo internalization in cells.<sup><xref ref-type="bibr" rid="bibr55-0885328211427473">55</xref></sup> Sahay et al. studied the endocytosis mechanism of Pluronic block copolymers, where they interfere with selected membrane trafficking processes by inserting their hydrophobic PPO chains into lipid bilayers and decreasing membrane microviscosity.<sup><xref ref-type="bibr" rid="bibr56-0885328211427473">56</xref></sup> The uptake of curcumin-loaded Pluronic/PCL micelles in the Caco2 cells could be attributed to these mechanisms induced by the Pluronic moiety.
<fig id="fig17-0885328211427473" position="float"><label>Figure 17.</label><caption><p>Cellular internalization of (a) empty Pluronic/PCL micelles in colorectal adenocarcinoma (Caco2) cells, (b) free curcumin, and (c) curcumin-loaded Pluronic/PCL micelles in Caco2 cells under fluorescence microscopic view.</p></caption><graphic xlink:href="10.1177_0885328211427473-fig17.tif"/>
</fig></p>
<p>Poor absorption and bioavailability are serious problems concerning therapeutic application of hydrophobic, poorly water-soluble molecules, which compel many poorly soluble compounds to be excluded very early in their screening process, regardless of how active these compounds are toward their molecular targets.<sup><xref ref-type="bibr" rid="bibr57-0885328211427473">57</xref>,<xref ref-type="bibr" rid="bibr58-0885328211427473">58</xref></sup> Curcumin, which suffers from low bioavailability problems, requires a suitable carrier/delivery system to overcome these obstacles without compromising its activity. Our study suggests that Pluronic/PCL delivery system could be a promising choice for administering curcumin without the loss of its therapeutic activity. The pronounced cellular uptake of the micelles in Caco2 cells and in vitro cytotoxicity profile of curcumin-loaded Pluronic/PCL micelles can be extrapolated to make it a promising cancer therapeutic.</p>
</sec>
<sec id="sec41-0885328211427473" sec-type="conclusions"><title>Conclusion</title>
<p>We attempted to synthesize Pluronic/PCL micelles for encapsulating the therapeutic agent, curcumin. The self-assembling tendency of the block copolymer in aqueous phase, indicated by their low CMC value, suggested the possibility of developing the micelles as a stable delivery vehicle for curcumin. Curcumin-loaded Pluronic/PCL micelles exhibited favorable loading, sustained release, and put forth better performance of in vitro cytotoxicity and cellular uptake in Caco2 cells compared to the native form. Our investigation highlighted the potential of Pluronic/PCL micelles to be considered as a suitable nanocarrier for curcumin for anticancer applications.</p>
</sec>
</body>
<back><ack>
<title>Acknowledgments</title>
<p>We express our sincere thanks to The Director, SCTIMST, BMT Wing for the facilities provided. This work was supported by the Department of Science and Technology, Government of India through the project ‘Facility for nano/microparticle based biomaterials—advanced drug delivery systems’ #8013, under the Drugs and Pharmaceuticals Research Program. The authors acknowledge the support by Dr M.R. Rekha for cell culture studies, Dr H.K. Varma for the FTIR facility, Willi Paul for AFM, Ezra Mikhail for DSC, and Nayana Joseph (Regional Research laboratory, Thiruvananthapuram) for <sup>1</sup>H NMR.</p></ack>
<ref-list>
<title>References</title>
<ref id="bibr1-0885328211427473"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>TM</given-names></name><name><surname>Cullis</surname><given-names>PR</given-names></name></person-group>. <article-title>Drug delivery systems: entering the mainstream</article-title>. <source>Science</source> <year>2004</year>; <volume>303</volume>: <fpage>1818</fpage>–<lpage>1822</lpage>.</citation></ref>
<ref id="bibr2-0885328211427473"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Farokhzad</surname><given-names>OC</given-names></name><name><surname>Langer</surname><given-names>R</given-names></name></person-group>. <article-title>Impact of nanotechnology on drug delivery</article-title>. <source>ACS Nano</source> <year>2009</year>; <volume>3</volume>: <fpage>16</fpage>–<lpage>20</lpage>.</citation></ref>
<ref id="bibr3-0885328211427473"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tatiana</surname><given-names>B</given-names></name></person-group>. <article-title>Multifunctional polymeric carriers for gene and drug delivery</article-title>. <source>Pharm Res</source> <year>2010</year>; <volume>27</volume>: <fpage>2257</fpage>–<lpage>2259</lpage>.</citation></ref>
<ref id="bibr4-0885328211427473"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Younghoon</surname><given-names>K</given-names></name><name><surname>Paul</surname><given-names>D</given-names></name><name><surname>David</surname><given-names>AC</given-names></name><name><surname>Dennis</surname><given-names>ED</given-names></name></person-group>. <article-title>Polymeric worm micelles as nano-carriers for drug delivery</article-title>. <source>Nanotechnology</source> <year>2005</year>; <volume>16</volume>: <fpage>484</fpage>–<lpage>491</lpage>.</citation></ref>
<ref id="bibr5-0885328211427473"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Torchilin</surname><given-names>VP</given-names></name></person-group>. <article-title>Structure and design of polymeric surfactant-based drug delivery systems</article-title>. <source>J Contr Release</source> <year>2001</year>; <volume>73</volume>: <fpage>137</fpage>–<lpage>172</lpage>.</citation></ref>
<ref id="bibr6-0885328211427473"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sutton</surname><given-names>D</given-names></name><name><surname>Nasongkla</surname><given-names>N</given-names></name><name><surname>Blanco</surname><given-names>E</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name></person-group>. <article-title>Functionalized micellar systems for cancer targeted drug delivery</article-title>. <source>Pharm Res</source> <year>2007</year>; <volume>24</volume>: <fpage>1029</fpage>–<lpage>1046</lpage>.</citation></ref>
<ref id="bibr7-0885328211427473"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Danson</surname><given-names>S</given-names></name><name><surname>Ferry</surname><given-names>D</given-names></name><name><surname>Alakhov</surname><given-names>V</given-names></name><name><surname>Margison</surname><given-names>J</given-names></name><name><surname>Kerr</surname><given-names>D</given-names></name><name><surname>Jowle</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Phase I dose escalation and pharmacokinetic study of pluronic polymerbound doxorubicin (SP1049C) in patients with advanced cancer</article-title>. <source>Br J Cancer</source> <year>2004</year>; <volume>90</volume>: <fpage>2085</fpage>–<lpage>2091</lpage>.</citation></ref>
<ref id="bibr8-0885328211427473"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matsumura</surname><given-names>Y</given-names></name><name><surname>Hamaguchi</surname><given-names>T</given-names></name><name><surname>Ura</surname><given-names>T</given-names></name><name><surname>Muro</surname><given-names>K</given-names></name><name><surname>Yamada</surname><given-names>Y</given-names></name><name><surname>Shimada</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin</article-title>. <source>Br J Cancer</source> <year>2004</year>; <volume>91</volume>: <fpage>1775</fpage>–<lpage>1781</lpage>.</citation></ref>
<ref id="bibr9-0885328211427473"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>TY</given-names></name><name><surname>Kim</surname><given-names>DW</given-names></name><name><surname>Chung</surname><given-names>JY</given-names></name><name><surname>Shin</surname><given-names>SG</given-names></name><name><surname>Kim</surname><given-names>SC</given-names></name><name><surname>Heo</surname><given-names>DS</given-names></name><etal/></person-group>. <article-title>Phase I and pharmacokinetic study of Genexol-PM a cremophor-free, polymeric micelle formulated paclitaxel, in patients with advanced malignancies</article-title>. <source>Clin Cancer Res</source> <year>2004</year>; <volume>10</volume>: <fpage>3708</fpage>–<lpage>3716</lpage>.</citation></ref>
<ref id="bibr10-0885328211427473"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maeda</surname><given-names>H</given-names></name><name><surname>Greish</surname><given-names>K</given-names></name><name><surname>Fang</surname><given-names>J</given-names></name></person-group>. <article-title>The EPR effect and polymeric drugs: a paradigm shift for cancer chemotherapy in the 21st century</article-title>. <source>Adv Polym Sci</source> <year>2006</year>; <volume>193</volume>: <fpage>103</fpage>–<lpage>121</lpage>.</citation></ref>
<ref id="bibr11-0885328211427473"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weir</surname><given-names>NM</given-names></name><name><surname>Selvendiran</surname><given-names>K</given-names></name><name><surname>Kutala</surname><given-names>VK</given-names></name><name><surname>Tong</surname><given-names>L</given-names></name><name><surname>Vishwanath</surname><given-names>S</given-names></name><name><surname>Rajaram</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPK</article-title>. <source>Cancer Biol Ther</source> <year>2007</year>; <volume>6</volume>: <fpage>178</fpage>–<lpage>184</lpage>.</citation></ref>
<ref id="bibr12-0885328211427473"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kuttan</surname><given-names>R</given-names></name><name><surname>Bhanumathy</surname><given-names>P</given-names></name><name><surname>Nirmala</surname><given-names>K</given-names></name><name><surname>George</surname><given-names>MC</given-names></name></person-group>. <article-title>Potential anticancer activity of turmeric (<italic>Curcuma longa</italic>)</article-title>. <source>Cancer Lett</source> <year>1998</year>; <volume>29</volume>: <fpage>197</fpage>–<lpage>202</lpage>.</citation></ref>
<ref id="bibr13-0885328211427473"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Aggarwal</surname><given-names>BB</given-names></name></person-group>. <article-title>Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane)</article-title>. <source>J Biol Chem</source> <year>1995</year>; <volume>270</volume>: <fpage>4995</fpage>–<lpage>5000</lpage>.</citation></ref>
<ref id="bibr14-0885328211427473"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kunnumakkara</surname><given-names>AB</given-names></name><name><surname>Anand</surname><given-names>P</given-names></name><name><surname>Aggarwal</surname><given-names>BB</given-names></name></person-group>. <article-title>Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins</article-title>. <source>Cancer Lett</source> <year>2008</year>; <volume>269</volume>: <fpage>199</fpage>–<lpage>225</lpage>.</citation></ref>
<ref id="bibr15-0885328211427473"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>JY</given-names></name><name><surname>Lin</surname><given-names>SJ</given-names></name><name><surname>Lin</surname><given-names>JK</given-names></name></person-group>. <article-title>Inhibitory effects of curcumin on protein kinase C activity induced by 12-<italic>O</italic>-tetradecanoyl-phorbol-13-acetate in NIH 3T3 cells</article-title>. <source>Carcinogenesis</source> <year>1993</year>; <volume>14</volume>: <fpage>857</fpage>–<lpage>861</lpage>.</citation></ref>
<ref id="bibr16-0885328211427473"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sahu</surname><given-names>A</given-names></name><name><surname>Kasoju</surname><given-names>N</given-names></name><name><surname>Bora</surname><given-names>U</given-names></name></person-group>. <article-title>Fluorescence study of the curcumin-casein micelle complexation and its application as a drug nanocarrier to cancer cells</article-title>. <source>Biomacromolecules</source> <year>2008</year>; <volume>9</volume>: <fpage>2905</fpage>–<lpage>2912</lpage>.</citation></ref>
<ref id="bibr17-0885328211427473"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sahu</surname><given-names>A</given-names></name><name><surname>Bora</surname><given-names>U</given-names></name><name><surname>Kasoju</surname><given-names>N</given-names></name><name><surname>Goswami</surname><given-names>P</given-names></name></person-group>. <article-title>Self-assembling methoxy poly(ethylene glycol)-palmitate nanocarrier for curcumin delivery to cancer cells</article-title>. <source>Acta Biomater</source> <year>2008</year>; <volume>4</volume>: <fpage>1752</fpage>–<lpage>1761</lpage>.</citation></ref>
<ref id="bibr18-0885328211427473"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bisht</surname><given-names>S</given-names></name><name><surname>Feldmann</surname><given-names>G</given-names></name><name><surname>Soni</surname><given-names>S</given-names></name><name><surname>Ravi</surname><given-names>R</given-names></name><name><surname>Karikar</surname><given-names>C</given-names></name><name><surname>Maitra</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Polymeric nanoparticle-encapsulated curcumin (“nanocurcumin”): a novel strategy for human cancer therapy</article-title>. <source>J Nanobiotechnol</source> <year>2007</year>; <volume>5</volume>: <fpage>3</fpage>–<lpage>3</lpage>.</citation></ref>
<ref id="bibr19-0885328211427473"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>So</surname><given-names>YK</given-names></name><name><surname>Jung</surname><given-names>CH</given-names></name><name><surname>Young</surname><given-names>ML</given-names></name></person-group>. <article-title>Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide)/poly(e-caprolactone) (PCL) amphiphilic block copolymeric nanospheres II-thermo-responsive drug release behaviors</article-title>. <source>J Contr Release</source> <year>2000</year>; <volume>65</volume>: <fpage>345</fpage>–<lpage>358</lpage>.</citation></ref>
<ref id="bibr20-0885328211427473"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>G</given-names></name><name><surname>Song</surname><given-names>C</given-names></name></person-group>. <article-title>PCL/Poloxamer 188 blend microsphere for paclitaxel delivery: influence of Poloxamer 188 on morphology and drug release</article-title>. <source>J Appl Polym Sci</source> <year>2007</year>; <volume>104</volume>: <fpage>1895</fpage>–<lpage>1899</lpage>.</citation></ref>
<ref id="bibr21-0885328211427473"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chandana</surname><given-names>M</given-names></name><name><surname>Sanjeeb</surname><given-names>KS</given-names></name></person-group>. <article-title>The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation</article-title>. <source>Biomaterials</source> <year>2010</year>; <volume>31</volume>: <fpage>6597</fpage>–<lpage>6611</lpage>.</citation></ref>
<ref id="bibr22-0885328211427473"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sahu</surname><given-names>A</given-names></name><name><surname>Kasoju</surname><given-names>N</given-names></name><name><surname>Goswami</surname><given-names>P</given-names></name><name><surname>Bora</surname><given-names>U</given-names></name></person-group>. <article-title>Encapsulation of curcumin in Pluronic block copolymer micelles for drug delivery applications</article-title>. <source>J Biomater Appl</source> <year>2011</year>; <volume>25</volume>: <fpage>619</fpage>–<lpage>639</lpage>.</citation></ref>
<ref id="bibr23-0885328211427473"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>X</given-names></name><name><surname>Macdonald</surname><given-names>DA</given-names></name><name><surname>Goosen</surname><given-names>MFA</given-names></name><name><surname>Mcauley</surname><given-names>KB</given-names></name></person-group>. <article-title>Mechanism of polymerization in the presence of stannous octoate: the effect of hydroxy and carboxylic acid substances</article-title>. <source>J Polym Sci: Part A: Polym Chem</source> <year>1994</year>; <volume>32</volume>: <fpage>2965</fpage>–<lpage>2970</lpage>.</citation></ref>
<ref id="bibr24-0885328211427473"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>CH</given-names></name><name><surname>So</surname><given-names>YK</given-names></name><name><surname>Young</surname><given-names>ML</given-names></name></person-group>. <article-title>Poly(ethylene oxide)–poly(propylene oxide)–poly(ethylene oxide) (Pluronic)/poly(ε-caprolactone) (PCL) amphiphilic block copolymeric nanospheres I – preparation and characterization</article-title>. <source>J Contr Release</source> <year>1999</year>; <volume>62</volume>: <fpage>381</fpage>–<lpage>392</lpage>.</citation></ref>
<ref id="bibr25-0885328211427473"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>RK</given-names></name><name><surname>Kasoju</surname><given-names>N</given-names></name><name><surname>Bora</surname><given-names>U</given-names></name></person-group>. <article-title>Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells</article-title>. <source>Nanomedicine: Nanotech Biol Med</source> <year>2010</year>; <volume>6</volume>: <fpage>153</fpage>–<lpage>160</lpage>.</citation></ref>
<ref id="bibr26-0885328211427473"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>DW</given-names></name><name><surname>Powers</surname><given-names>K</given-names></name><name><surname>Baney</surname><given-names>R</given-names></name></person-group>. <article-title>Physicochemical properties and blood compatibility of acylated chitosan nanoparticles</article-title>. <source>Carb Polym</source> <year>2004</year>; <volume>58</volume>: <fpage>371</fpage>–<lpage>377</lpage>.</citation></ref>
<ref id="bibr27-0885328211427473"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kainthan</surname><given-names>RK</given-names></name><name><surname>Gnanamani</surname><given-names>M</given-names></name><name><surname>Ganguli</surname><given-names>M</given-names></name><name><surname>Ghosh</surname><given-names>T</given-names></name><name><surname>Brooks</surname><given-names>DE</given-names></name><name><surname>Maiti</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Blood compatibility of novel water soluble hyperbranched polyglycerol-based multivalent cationic polymers and their interaction with DNA</article-title>. <source>Biomaterials</source> <year>2006</year>; <volume>27</volume>: <fpage>5377</fpage>–<lpage>5390</lpage>.</citation></ref>
<ref id="bibr28-0885328211427473"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yen</surname><given-names>FL</given-names></name><name><surname>Wu</surname><given-names>TH</given-names></name><name><surname>Tzeng</surname><given-names>CW</given-names></name><name><surname>Lin</surname><given-names>LT</given-names></name><name><surname>Lin</surname><given-names>CC</given-names></name></person-group>. <article-title>Curcumin nanoparticles improve the physicochemical properties of curcumin and effectively enhance its antioxidant and antihepatoma activities</article-title>. <source>J Agric Food Chem</source> <year>2010</year>; <volume>58</volume>: <fpage>7376</fpage>–<lpage>7382</lpage>.</citation></ref>
<ref id="bibr29-0885328211427473"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lü</surname><given-names>F</given-names></name><name><surname>Fang</surname><given-names>Y</given-names></name><name><surname>and Blanchard</surname><given-names>GJ</given-names></name></person-group>. <article-title>Probing the microenvironment of surface-attached pyrene formed by a thermo-responsive oligomer</article-title>. <source>Spectrochim Acta A Mol Biomol Spectrosc</source> <year>2009</year>; <volume>74</volume>: <fpage>991</fpage>–<lpage>999</lpage>.</citation></ref>
<ref id="bibr30-0885328211427473"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xiong</surname><given-names>XY</given-names></name><name><surname>Tam</surname><given-names>KC</given-names></name><name><surname>Gan</surname><given-names>LH</given-names></name></person-group>. <article-title>Synthesis and thermally responsive properties properties of novel Pluronic F87/Polycaprolactone (PCL) block copolymers with short PCL blocks</article-title>. <source>J Appl Polym Sci</source> <year>2006</year>; <volume>100</volume>: <fpage>4163</fpage>–<lpage>4172</lpage>.</citation></ref>
<ref id="bibr31-0885328211427473"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mohanty</surname><given-names>A</given-names></name><name><surname>Mohanty</surname><given-names>D</given-names></name><name><surname>Sahoo</surname><given-names>K</given-names></name></person-group>. <article-title>Curcumin-encapsulated MePEG/PCL diblock copolymeric micelles: a novel controlled delivery vehicle for cancer therapy</article-title>. <source>Nanomedicine</source> <year>2010</year>; <volume>5</volume>: <fpage>433</fpage>–<lpage>449</lpage>.</citation></ref>
<ref id="bibr32-0885328211427473"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>SS</given-names></name></person-group>. <article-title>Nanoparticles of biodegradable polymers for new concept chemotherapy</article-title>. <source>Expert Rev Med Devices</source> <year>2004</year>; <volume>1</volume>: <fpage>115</fpage>–<lpage>125</lpage>.</citation></ref>
<ref id="bibr33-0885328211427473"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mohanraj</surname><given-names>VJ</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name></person-group>. <article-title>Nanoparticles—a review</article-title>. <source>Trop J Pharm Res</source> <year>2006</year>; <volume>5</volume>: <fpage>561</fpage>–<lpage>573</lpage>.</citation></ref>
<ref id="bibr34-0885328211427473"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pignatello</surname><given-names>R</given-names></name><name><surname>Francesco</surname><given-names>CF</given-names></name></person-group>. <article-title>Calorimetric techniques to study the interaction of drugs with biomembrane models</article-title>. <source>J Pharm Bioallied Sci</source> <year>2011</year>; <volume>3</volume>: <fpage>1</fpage>–<lpage>2</lpage>.</citation></ref>
<ref id="bibr35-0885328211427473"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vinogradov</surname><given-names>S</given-names></name><name><surname>Batrakova</surname><given-names>E</given-names></name><name><surname>Kabanov</surname><given-names>A</given-names></name></person-group>. <article-title>Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA–mPEG nanoparticles</article-title>. <source>Int J Pharm</source> <year>2003</year>; <volume>259</volume>: <fpage>115</fpage>–<lpage>127</lpage>.</citation></ref>
<ref id="bibr36-0885328211427473"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Acharya</surname><given-names>S</given-names></name><name><surname>Dilnawaz</surname><given-names>F</given-names></name><name><surname>Sahoo</surname><given-names>SK</given-names></name></person-group>. <article-title>Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy</article-title>. <source>Biomaterials</source> <year>2009</year>; <volume>30</volume>: <fpage>5737</fpage>–<lpage>5750</lpage>.</citation></ref>
<ref id="bibr37-0885328211427473"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mohanty</surname><given-names>C</given-names></name><name><surname>Sahoo</surname><given-names>K</given-names></name></person-group>. <article-title>The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation</article-title>. <source>Biomaterials</source> <year>2010</year>; <volume>1</volume>: <fpage>6597</fpage>–<lpage>6611</lpage>.</citation></ref>
<ref id="bibr38-0885328211427473"><label>38</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Horbett</surname><given-names>TA</given-names></name><name><surname>Brash</surname><given-names>JL</given-names></name></person-group>. <article-title>Proteins at interfaces. Physicochemical and biochemical studies</article-title>. In: <person-group person-group-type="editor"><name><surname>Horbett</surname><given-names>TA</given-names></name><name><surname>Brash</surname><given-names>JL</given-names></name></person-group> (eds) <source>Proteins at interfaces</source> , <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>American Chemical Society</publisher-name>, <year>1987</year>, pp. <fpage>1</fpage>–<lpage>33</lpage>.</citation></ref>
<ref id="bibr39-0885328211427473"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Horbett</surname><given-names>TA</given-names></name></person-group>. <article-title>Principles underlying the role of adsorbed plasma proteins in blood interactions with foreign materials</article-title>. <source>Cardiovasc Pathol</source> <year>1993</year>; <volume>2</volume>: <fpage>137</fpage>–<lpage>148</lpage>.</citation></ref>
<ref id="bibr40-0885328211427473"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jeon</surname><given-names>SI</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Andrade</surname><given-names>JD</given-names></name><name><surname>De Gennes</surname><given-names>PG</given-names></name></person-group>. <article-title>Protein-surface interactions in the presence of polyethylene oxide: I. Simplified theory</article-title>. <source>J Colloid Interface Sci</source> <year>1991</year>; <volume>142</volume>: <fpage>149</fpage>–<lpage>158</lpage>.</citation></ref>
<ref id="bibr41-0885328211427473"><label>41</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Yokoyama</surname><given-names>M</given-names></name></person-group>. <article-title>Novel passive targetable drug delivery with polymeric micelles</article-title>. In: <person-group person-group-type="editor"><name><surname>Okano</surname><given-names>T</given-names></name></person-group> (ed.) <source>Biorelated polymers and gels</source> , <publisher-loc>San Diego, CA</publisher-loc>: <publisher-name>Academic Press</publisher-name>, <year>1998</year>, pp. <fpage>193</fpage>–<lpage>229</lpage>.</citation></ref>
<ref id="bibr42-0885328211427473"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Richard</surname><given-names>AM</given-names></name></person-group>. <article-title>Plasma hemoglobin measurement techniques for the in vitro evaluation of blood damage caused by medical devices</article-title>. <source>Artif Organs</source> <year>1997</year>; <volume>21</volume>: <fpage>1255</fpage>–<lpage>1267</lpage>.</citation></ref>
<ref id="bibr43-0885328211427473"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rekha</surname><given-names>MR</given-names></name><name><surname>Sharma</surname><given-names>CP</given-names></name></person-group>. <article-title>Hemocompatible pullulan–polyethyleneimine conjugates for liver cell gene delivery: in vitro evaluation of cellular uptake, intracellular trafficking and transfection efficiency</article-title>. <source>Acta Biomater</source> <year>2011</year>; <volume>7</volume>: <fpage>370</fpage>–<lpage>379</lpage>.</citation></ref>
<ref id="bibr44-0885328211427473"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Choudhuri</surname><given-names>T</given-names></name><name><surname>Pal</surname><given-names>S</given-names></name><name><surname>Agwarwal</surname><given-names>ML</given-names></name><name><surname>Das</surname><given-names>T</given-names></name><name><surname>Sa</surname><given-names>G</given-names></name></person-group>. <article-title>Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction</article-title>. <source>FEBS Lett</source> <year>2002</year>; <volume>512</volume>: <fpage>334</fpage>–<lpage>340</lpage>.</citation></ref>
<ref id="bibr45-0885328211427473"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Joshy</surname><given-names>KS</given-names></name><name><surname>Paul</surname><given-names>W</given-names></name><name><surname>Sharma</surname><given-names>CP</given-names></name></person-group>. <article-title>Copper complexed polymer carriers for IgG adsorption</article-title>. <source>J Colloid Interface Sci</source> <year>2010</year>; <volume>352</volume>: <fpage>178</fpage>–<lpage>185</lpage>.</citation></ref>
<ref id="bibr46-0885328211427473"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mao</surname><given-names>C</given-names></name><name><surname>Liang</surname><given-names>CX</given-names></name><name><surname>Mao</surname><given-names>YQ</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Hou</surname><given-names>XM</given-names></name><name><surname>Shen</surname><given-names>J</given-names></name></person-group>. <article-title>Modification of polyethylene with Pluronics F127 for improvement of blood compatibility</article-title>. <source>Colloids Surf B: Biointerfaces</source> <year>2009</year>; <volume>74</volume>: <fpage>362</fpage>–<lpage>365</lpage>.</citation></ref>
<ref id="bibr47-0885328211427473"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>YJ</given-names></name><name><surname>Pan</surname><given-names>MH</given-names></name><name><surname>Cheng</surname><given-names>AL</given-names></name><name><surname>Lin</surname><given-names>LI</given-names></name><name><surname>Ho</surname><given-names>YS</given-names></name><name><surname>Hsieh</surname><given-names>CY</given-names></name><etal/></person-group>. <article-title>Stability of curcumin in buffer solutions and characterization of its degradation products</article-title>. <source>J Pharm Biomed Anal</source> <year>1997</year>; <volume>15</volume>: <fpage>1867</fpage>–<lpage>1876</lpage>.</citation></ref>
<ref id="bibr48-0885328211427473"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname><given-names>MHM</given-names></name><name><surname>Colangelo</surname><given-names>H</given-names></name><name><surname>Kee</surname><given-names>TW</given-names></name></person-group>. <article-title>Encapsulation of curcumin in cationic micellae suppresses alkaline hydrolysis</article-title>. <source>Langmuir</source> <year>2008</year>; <volume>24</volume>: <fpage>5672</fpage>–<lpage>5675</lpage>.</citation></ref>
<ref id="bibr49-0885328211427473"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lev-Ari</surname><given-names>S</given-names></name><name><surname>Strier</surname><given-names>L</given-names></name><name><surname>Kazanov</surname><given-names>D</given-names></name></person-group>. <article-title>Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells</article-title>. <source>Clin Cancer Res</source> <year>2005</year>; <volume>11</volume>: <fpage>6738</fpage>–<lpage>6744</lpage>.</citation></ref>
<ref id="bibr50-0885328211427473"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>Z</given-names></name><name><surname>Haddadi</surname><given-names>A</given-names></name><name><surname>Molavi</surname><given-names>O</given-names></name><name><surname>Lavasanifar</surname><given-names>A</given-names></name><name><surname>Lai</surname><given-names>R</given-names></name><name><surname>Samuel</surname><given-names>J</given-names></name></person-group>. <article-title>Micelles of poly(ethylene oxide)-<italic>b</italic>-poly(e-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin</article-title>. <source>J Biomed Mater Res A</source> <year>2008</year>; <volume>86</volume>: <fpage>300</fpage>–<lpage>310</lpage>.</citation></ref>
<ref id="bibr51-0885328211427473"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lev-Ari</surname><given-names>S</given-names></name><name><surname>Strier</surname><given-names>L</given-names></name><name><surname>Kazanov</surname><given-names>D</given-names></name></person-group>. <article-title>Curcumin synergistically potentiates the growth-inhibitory and pro-apoptotic effects of celecoxib in osteoarthritis synovial adherent cells</article-title>. <source>Rheumatology</source> <year>2006</year>; <volume>45</volume>: <fpage>171</fpage>–<lpage>177</lpage>.</citation></ref>
<ref id="bibr52-0885328211427473"><label>52</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lev-Ari</surname><given-names>S</given-names></name><name><surname>Vexler</surname><given-names>A</given-names></name><name><surname>Starr</surname><given-names>A</given-names></name></person-group>. <article-title>Curcumin augments gemcitabine cytotoxic effect on pancreatic adenocarcinoma cell lines</article-title>. <source>Cancer Invest</source> <year>2007</year>; <volume>25</volume>: <fpage>411</fpage>–<lpage>418</lpage>.</citation></ref>
<ref id="bibr53-0885328211427473"><label>53</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name></person-group>. <article-title>The effect of Poloxamer 188 on nanoparticle morphology, size, cancer cell uptake and cytotoxicity</article-title>. <source>Nanomedicine: NBM</source> <year>2010</year>; <volume>6</volume>: <fpage>170</fpage>–<lpage>178</lpage>.</citation></ref>
<ref id="bibr54-0885328211427473"><label>54</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mei</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name></person-group>. <article-title>A novel docetaxel-loaded poly(ε-caprolactone)/Pluronic F68 nanoparticle overcoming multidrug resistance for breast cancer treatment</article-title>. <source>Nanoscale Res Lett</source> <year>2009</year>; <volume>4</volume>: <fpage>1530</fpage>–<lpage>1539</lpage>.</citation></ref>
<ref id="bibr55-0885328211427473"><label>55</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Batrakova</surname><given-names>EV</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Vinogradov</surname><given-names>SV</given-names></name><name><surname>Alakhov</surname><given-names>VY</given-names></name><name><surname>Miller</surname><given-names>DW</given-names></name><name><surname>Kabanov</surname><given-names>AV</given-names></name></person-group>. <article-title>Mechanism of pluronic effect on P-glycoprotein efflux system in blood-brain barrier: contributions of energy depletion and membrane fluidization</article-title>. <source>J Pharmacol Exp Ther</source> <year>2001</year>; <volume>299</volume>: <fpage>483</fpage>–<lpage>493</lpage>.</citation></ref>
<ref id="bibr56-0885328211427473"><label>56</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sahay</surname><given-names>G</given-names></name><name><surname>Batrakova</surname><given-names>EV</given-names></name><name><surname>Kabanov</surname><given-names>AV</given-names></name></person-group>. <article-title>Different internalization pathways of polymeric micelles and unimers and their effects on vesicular transport</article-title>. <source>Bioconjugate Chem</source> <year>2008</year>; <volume>19</volume>: <fpage>2023</fpage>–<lpage>2029</lpage>.</citation></ref>
<ref id="bibr57-0885328211427473"><label>57</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>IG</given-names></name><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Lee</surname><given-names>YM</given-names></name><name><surname>Cho</surname><given-names>CS</given-names></name><name><surname>Sung</surname><given-names>YK</given-names></name></person-group>. <article-title>Methoxy poly (ethylene glycol)/ε-caprolactone amphiphilic block copolymeric micelle containing indomethacin: I. Preparation and characterization</article-title>. <source>J Contr Release</source> <year>1998</year>; <volume>51</volume>: <fpage>1</fpage>–<lpage>11</lpage>.</citation></ref>
<ref id="bibr58-0885328211427473"><label>58</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Shin</surname><given-names>IG</given-names></name><name><surname>Lee</surname><given-names>YM</given-names></name></person-group>. <article-title>Preparation and characterization of biodegradable nanospheres composed of methoxy poly(ethylene glycol) and DL-lactide block copolymer as novel drug carriers</article-title>. <source>J Contr Release</source> <year>1998</year>; <volume>56</volume>: <fpage>197</fpage>–<lpage>208</lpage>.</citation></ref>
</ref-list>
</back>
</article>